The present invention provides a combination including a double-balloon
catheter and a nucleic acid encoding the cyclin dependent kinase
inhibitor p21. The nucleic acid may also encode HLA-B7, an
immunotherapeutic agent, a cytokine or a prodrug converting enzyme.